Course Objectives

Understand how to define BPD and if short term outcomes correlate with longer term outcomes.
Understand the factors that contribute to the development of BPD.
Understand treatment options for the prevention and treatment of BPD.
Recognize variability in post-discharge growth trajectories of preterm infants.
Describe feeding plans for breastfed and formula-fed preterm infants after NICU discharge.
Identify risks and benefits of introducing complementary feeding in preterm infants.
Describe the evidence for the prophylactic use of caffeine in extremely preterm infants.
Understand current controversies in the use of caffeine in preterm infants.

Identify how BPD is defined, diagnosed and treated and how those treatments lead to outcomes.
Know how to develop a BPD Service to provide optimal therapies.
Understand the results of recent completed and current genomic sequencing trials in newborns.
Identify the ethical considerations associated with integrating genomic sequencing at birth.
Understand difficulties developing drugs and devices for children.
Understand how real-world data and genomic sequencing will improve drug development.
Describe methods to evaluate GER in preterm infants.
Understand the risks and benefits of treating signs of GER in preterm infants.

Examine the evidence for using donor milk to attain early enteral nutrition, reduce healthcare costs and decrease length of stay.
Understand barriers to use of donor milk in the NICU and how to overcome them.
Understand the scope of the problem of infant mortality from a global perspective.
Recognize barriers and disparities preventing better neonatal outcomes in developing countries.
Understand new ways to prevent intestinal inflammation in necrotizing enterocolitis.
Review new directions in NEC, including model systems and personalized medicine approaches.
Better understand how maternal factors contribute to the development of NAS.
Better understand the definition, assessment, and treatment of NAS.

Describe the current use of antibiotics in the NICU.
Describe methods to reduce antibiotic overuse in the NICU.
Appreciate the status of integrating novel salivary diagnostic platforms in neonatal care.
Understand saliva’s ability to assess inflammation, infection, and development in the newborn.
Identify how standardized guidelines for key interventions improve survival and outcomes in extremely preterm infants.
Recognize how enhancing parental involvement improves parent engagement and outcomes.
Learn about potential new serum biomarkers for necrotizing enterocolitis.
Discuss new potential stool biomarkers for necrotizing enterocolitis.

Last Updated on January 30, 2025 by SENEO